Projects approved for funding in 2024
| Code | Title | Organisation | Lead PI | Funding Amount | Abstract | Final Summary |
| TCS/24/05 | Proving the Utility of Field Cycling Imaging in Small Vessel Disease – a focus on Brain Health (PUFFINS-BH) | University of Aberdeen | Dr Gordon Waiter | £349,956 | TCS/24/05 Abstract | Project Active |
| TCS/24/08 | Targeted, Stimuli-Responsive Delivery of Senolytics from Metal-Organic Frameworks | University of Glasgow | Professor Ross Forgan | £279,955 | TCS/24/08 Abstract | Project Active |
| TCS/24/09 | Predicting Response in Triple Negative Breast Cancer Using Machine Learning | University of Aberdeen | Professor Valerie Speirs | £343,333 | TCS/24/09 Abstract | Project Active |
| TCS/24/15 | Early detection of glaucoma in primary care using artificial intelligence aided analysis of retinal images | University of Edinburgh | Dr Andrew Tatham | £349,565 | TCS/24/15 Abstract | Project Active |
| TCS/24/35 | Applying New MRI Technology To Improve Outcomes From Chemoradiotherapy Treatment For Adult Patients With Glioblastoma | University of Aberdeen | Professor Anne Kiltie | £349,033 | TCS/24/35 Abstract | Project Active |
| TCS/24/39 | Regression Evaluation of pancreatic cancer using Single-cell sPatial multi-Omics following Neoadjuvant therapy for Survival Enhancement (RESPONSE) | University of Glasgow | Professor Nigel Jamieson | £348,150 | TCS/24/39 Abstract | Project Active |
| TCS/24/40 | Computer-Based Eye Movement Training For Stroke-Related Visual Field Loss: A Pilot Randomised Controlled Trial (CRYSTAL) | Glasgow Caledonian University | Dr Christine Hazelton | £349,901 | TCS/24/40 Abstract | Project Active |
| TCS/24/42 | Total Neoadjuvant Treatment In Oesophageal Adenocarcinoma: The TNT-OAC Trial Feasibility | University of Dundee | Dr Russell Petty | £349,366 | TCS/24/42 Abstract | Project Active |